<mods:mods xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" version="3.3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mods="http://www.loc.gov/mods/v3"><mods:titleInfo><mods:title>SJÖGREN’S SYNDROME</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">Yo‘ldosheva Zilola</mods:namePart><mods:namePart type="family">Yo‘ldosheva Zilola</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">Ruziyeva Sitora</mods:namePart><mods:namePart type="family">Ruziyeva Sitora</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>Sjögren’s syndrome is a systemic autoimmune disease that affects connective tissues, primarily involving the exocrine glands—mainly the salivary and lacrimal glands—in the pathological process and progresses chronically. As a result of this process, dryness of the mouth (xerostomia) and dryness of the eyes (xerophthalmia) are observed. The disease can occur independently in its primary form or develop as a secondary form together with other autoimmune diseases such as rheumatoid arthritis or systemic lupus erythematosus. This article provides a scientific analysis of the pathogenetic mechanisms, clinical features, diagnostic criteria, and preventive measures of Sjögren’s syndrome. The results of the study emphasize the scientific and practical significance of early detection and effective management of the disease to promote a healthy lifestyle among the population.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2025-11-27</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>